Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Cannabidiol oil and THC-A oil; permitting of pharmaceutical processors to manufacture and provide. | Authorizes a pharmaceutical processor, after obtaining a permit from the Board of Pharmacy (the Board) and under the supervision of a licensed pharmacist, to manufacture and provide cannabidiol oil and THC-A oil to be used for the treatment of intractable epilepsy. The bill sets limits on the number of permits that the Board may issue and requires that the Board adopt regulations establishing health, safety, and security requirements for permitted processors. The bill provides that only a licensed practitioner of medicine or osteopathy who is a neurologist or who specializes in the treatment of epilepsy may issue a written certification to a patient for the use of cannabidiol oil or THC-A oil. The bill also requires that a practitioner who issues a written certification for cannabidiol oil or THC-A oil, the patient issued such certification, and, if the patient is a minor or incapacitated, the patient's parent or legal guardian register with the Board. The bill requires further that a pharmaceutical processor shall not provide cannabidiol oil or THC-A oil to a patient or a patient's parent or legal guardian without first verifying that the patient, the patient's parent or legal guardian if the patient is a minor or incapacitated, and the practitioner who issued the written certification have registered with the Board. Finally, the bill provides an affirmative defense for agents and employees of pharmaceutical processors in a prosecution for the manufacture, possession, or distribution of marijuana. The bill contains an emergency clause. | us/states/va | Virginia General Assembly | 2017 | SB 1027 | Virginia SB 1027 (2017) |
|
|
enacted |
|
4 | 23 | 7 | 2017-01-04 | 2017-03-16 | openstates | ocd-bill/79a3af80-5ffd-4e3c-919e-cf762ea36d9d | http://lis.virginia.gov/cgi-bin/legp604.exe?171+sum+SB1027 | c7bcc971ad3525f1b148db667e46f1862c2f3933ab45aa3762dee8a9bd7ee504 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 1027 (2017) — Cannabidiol oil and THC-A oil; permitting of pharmaceutical processors to manufacture and provide.
Authorizes a pharmaceutical processor, after obtaining a permit from the Board of Pharmacy (the Board) and under the supervision of a licensed pharmacist, to manufacture and provide cannabidiol oil and THC-A oil to be used for the treatment of intractable epilepsy. The bill sets limits on the number of permits that the Board may issue and requires that the Board adopt regulations establishing health, safety, and security requirements for permitted processors. The bill provides that only a licensed practitioner of medicine or osteopathy who is a neurologist or who specializes in the treatment of epilepsy may issue a written certification to a patient for the use of cannabidiol oil or THC-A oil. The bill also requires that a practitioner who issues a written certification for cannabidiol oil or THC-A oil, the patient issued such certification, and, if the patient is a minor or incapacitated, the patient's parent or legal guardian register with the Board. The bill requires further that a pharmaceutical processor shall not provide cannabidiol oil or THC-A oil to a patient or a patient's parent or legal guardian without first verifying that the patient, the patient's parent or legal guardian if the patient is a minor or incapacitated, and the practitioner who issued the written certification have registered with the Board. Finally, the bill provides an affirmative defense for agents and employees of pharmaceutical processors in a prosecution for the manufacture, possession, or distribution of marijuana. The bill contains an emergency clause.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Governor: Acts of Assembly Chapter text (CHAP0613) (committee substitute) — source
- House: Committee substitute printed 17105443D-H1 (committee substitute) — source
- Senate: Bill text as passed Senate and House (SB1027ER) (committee substitute) — source
- Senate: Prefiled and ordered printed with emergency clause; offered 01/13/16 17101565D (committee substitute) — source
Votes
- Reported from Courts of Justice with substitute — 20–0 (pass) · legislature
- Passed House with substitute with amendment — 99–0 (pass) · legislature
- Subcommittee recommends reporting with substitute — 10–0 (pass) · legislature
- House substitute with amendment agreed to by Senate — 38–0 (pass) · legislature
- Constitutional reading dispensed — 38–0 (pass) · legislature
- Read third time and passed Senate — 40–0 (pass) · legislature
- Reported from Education and Health — 14–1 (pass) · legislature
Sponsors
- David W. Marsden — primary (person)
- Adam P. Ebbin — cosponsor (person)
- Betsy B. Carr — cosponsor (person)
- Eileen Filler-Corn — cosponsor (person)
- James M. LeMunyon — cosponsor (person)
- T. Montgomery "Monty" Mason — cosponsor (person)
- Vivian E. Watts — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-01-04 Prefiled and ordered printed with emergency clause; offered 01/13/16 17101565D
introduction - 2017-01-04 Referred to Committee on Education and Health
referral-committee - 2017-01-16 Assigned Education sub: Health Professions
referral-committee - 2017-01-23 Read second time and engrossed
reading-2 - 2017-01-30 Placed on Calendar
- 2017-01-30 Read first time
reading-1 - 2017-01-30 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2017-02-09 Referred from Health, Welfare and Institutions by voice vote
- 2017-02-09 Referred to Committee for Courts of Justice
referral-committee - 2017-02-10 Assigned Courts sub: Criminal Law
referral-committee - 2017-02-14 Read second time
reading-2 - 2017-02-15 Read third time
reading-3 - 2017-02-15 Committee substitute agreed to 17105443D-H1
- 2017-02-15 Amendment by Delegate Albo agreed to
amendment-passage - 2017-02-15 Engrossed by House - committee substitute with amendment SB1027H1
- 2017-02-15 Passed House with substitute with amendment (99-Y 0-N)
passage - 2017-02-15 Title replaced 17105443D-H1
- 2017-02-20 Enrolled
- 2017-02-20 Signed by Speaker
- 2017-02-21 Signed by President
- 2017-02-21 Enrolled Bill communicated to Governor on 2/21/17
- 2017-02-21 Governor's Action Deadline Midnight, March 27, 2017
- 2017-03-16 Approved by Governor-Chapter 613 (effective 3/16/17)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/79a3af80-5ffd-4e3c-919e-cf762ea36d9d. Confidence: reported (aggregated from official Virginia legislature records).